Video & Transcript Research : 'pharmacy compounding'
Page 13 of 218
LA
Louisiana 2026 Regular Session
House of Representatives Mar 25th, 2026
Louisiana House Floor Meeting
Transcript Highlights:
- House Bill 557 by Representative DeWitt, long-term care, definition, long-term care pharmacy.
- House Bill 557 by Representative DeWitt, long-term care, definition, long-term care pharmacy.
- Wyrtsim DeWitt, long-term care, definition, long-term care, pharmacy, health and welfare with amendments
Bills:
HR65, HR66, HR67, HR68, HR69, HCR33, HCR34, HB1006, HB1007, HB1008, HB1010, HB1011, HR58, HR59, HR60, HR61, HR62, HR63, HR64, HCR32, SCR2, SCR5, SCR6, SCR11, SCR16, SCR17, HB43, HB447, HB573, HB1000, HB1001, HB1002, HB1003, HB1004, HB1005, SB8, SB10, SB12, SB16, SB20, SB21, SB22, SB29, SB32, SB41, SB42, SB44, SB49, SB58, SB68, SB75, SB77, SB81, SB97, SB103, SB159, SB163, SB172, SB180, SB182, SB244, SB248, SB253, SB254, SB279, SB306, SB318, SB334, SB380, SB385, SB397, HB53, HB57, HB64, HB100, HB102, HB106, HB111, HB137, HB152, HB155, HB177, HB238, HB256, HB258, HB272, HB337, HB350, HB359, HB363, HB386, HB434, HB445, HB546, HB557, HB584, HB661, HB697, HB726, HB727, HB747, HB752, HB756, HB758, HB759, HB765, HB767, HB825, HB858, HB930, HB941, HB957, HB964, HB203, HB228, HB234, HB260, HB268, HB271, HB285, HB289, HB351, HB400, HB413, HB469, HB534, HB551, HB552, HB574, HB576, HB634, HB649, HB677, HB735, HB739, HB779, HB784, HB796, HB842, HB850, HB919, HB8, HB9, HB10, HB15, HB16, HB17, HB18, HB19, HB22, HB33, HB34, HB35, HB44, HB46, HB47, HB48, HB61, HB101, HB126, HB135, HB142, HB164, HB185, HB215, HB226, HB232, HB233, HB242, HB284, HB292, HB297, HB301, HB334, HB436, HB468, HB548, HB571, HB582, HB593, HB594, HB609, HB613, HB712, HB722, HB732, HB746, HB827, HB845, HB848, HB921, HB923, HB951, HB953, HB999, HB733, HB875, HB952, HB868, HB119, HB140, HB52, HB901, HB193, HB570
Keywords:
condolences, Sam Goodwin, Northwestern State University, football coach, athletic legacy, obituary, ShaMonica Huggins, Louisiana, community support, public service, law enforcement, memorial resolution, Louisiana Legislature, tribute, centenarian, community recognition, Louisiana history, birthday celebration, Jeanerette, French bread
HI
Hawaii 2026 Regular Session
FIN Info Briefing - Tue Jan 6, 2026 @ 9:00 AM HST
Hawaii House Floor Meeting
Transcript Highlights:
- </c> and so the it just compounded the issue. and so the it just compounded the issue.
- ,</c><01:42:43.840><c> and</c> the Daniel Anoi College of Pharmacy, and the Daniel Anoi College of Pharmacy
- But the, uh, School of Pharmacy, um, Daniel K.
- ><c> partnering</c><02:07:46.880><c> more</c> um pharmacy has been partnering more um pharmacy has been
- </c> pharmacy to grow as we move forward. pharmacy to grow as we move forward.
TX
Texas 89th Regular
Appropriations - S/C on Article III Feb 26th, 2025
Appropriations - S/C on Article III
Transcript Highlights:
- elsewhere, to harness UT Austin's expertise and talent across engineering, AI, robotics. life sciences, pharmacy
- artery stent, HER2 breast cancer target, MRI image construction algorithm. the rapamycin anti-aging compound
- The Ben and Maytie Fish College of Pharmacy was founded in 2013 in response to a need for more pharmacies
- We got to go very early on. in life, because that's when those diseases started. is compounded by, for
OK
Oklahoma 2026 Regular Session
House of Representatives Second Regular Session of the 60th Legislature Day 41 Apr 15th, 2026 at 01:30 pm
Oklahoma House Floor Meeting
Transcript Highlights:
- Senate Bill 2074 is a pharmacy bill to protect our pharmacists from What has become a broken market.
- Our pharmacies are dying on the vine out here as a result of this market.
- Well, that's because they were filling all those prescriptions at their mail order pharmacy that day,
- This also helps the bigger pharmacies as well.
- So, below market pricing will close the pharmacies that we need.
Bills:
HR1051, HR1048, SB2074, SJR39, SJR47, SB1983, SB444, SB1503, SB1561, SB592, SB1501, SB1946, SB1567, SB1833, SB2026, SB904, SB2178, SB1651, SB1558, SB1565, SB1553, SB1257, SB65, SB1749, SB1242, SB1642, SB640, SB667, SB1436, SB1484, SB1562, SB1794, SB1644, SB1533, SB933, SB1555
Keywords:
livestock, judging, Oklahoma State University, championship, agriculture, military children, recognition, community support, military families, April 15, pharmacy benefits managers, reimbursement, healthcare, prescription drugs, cost regulation, property valuation, tax limit, homestead, income threshold, elderly
WA
Washington 2025-2026 Regular Session
Senate Ways & Means Mar 9th, 2026
Transcript Highlights:
- portion of that revenue also pay the business and occupation tax, and then potentially also pay the compounding
- Nowadays, insurance companies are tangled up with pharmacy benefit managers and an increasing array of
- Nowadays, insurance companies are tangled up with pharmacy benefit managers and an increasing Nowadays
- , insurance companies are tangled up with pharmacy benefit managers and an increasing array of side business
Summary:
The Ways and Means Committee held its last scheduled public hearing of the year on March 9, 2026, taking testimony on House Bill 2487, Substitute House Bill 2689, and Engrossed House Bill 2681. For HB 2487, staff and the Department of Revenue explained that the bill would narrow a B&O tax exemption for insurance-related businesses after a 2024 Supreme Court decision, make several related changes including annuity and assigned risk plan exemptions, adjust the advanced computing surcharge threshold for certain affiliated groups, and allow a penalties-and-interest waiver with a repayment plan. DOR supported the bill as clarifying the original intent and preventing double taxation, while insurers and health plan groups opposed it, arguing it would create higher costs, retroactive tax liability, and uncertainty; consumer and policy groups testified in support, saying it closes a loophole and restores the intended tax structure. Committee members questioned the retroactivity, the number of affected businesses, and the fiscal estimates, and the chair reminded members that amendment requests were due by noon for the next day’s executive session.
For Substitute HB 2689, staff described changes to the Working Connections Child Care program that would keep income eligibility at 60% of state median income, reduce future rate-setting from the 85th to the 75th percentile, block enhanced rates for certain cross-region providers, cancel the planned move to enrollment-based prospective payments, revise attendance-based reimbursement to a full month for absences of 10 days or fewer and half-month for longer absences, and require a 65% market survey response rate for validity. The fiscal note projected substantial savings, offset by implementation and staffing costs. SEIU 925 and Head Start representatives supported the simpler House approach to attendance billing but raised concerns about the new survey threshold and the risk of increased audits and provider burden; they also noted an amendment under discussion to address the 2026 survey issue. Committee questions focused on how a full month is defined under the attendance rules.
For HB 2681, staff said the bill would raise annual issuance and renewal fees for cannabis producer, processor, and retail licenses by $400, generating about $866,000 per year for the dedicated cannabis account with minimal administrative cost. No one signed up to testify, and the chair closed the hearing without a vote on any of the bills. The chair also thanked committee staff for their work and reiterated that amendments for the heard bills were due by noon that day.
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Health Care Financing Jun 21st, 2026 at 11:00 am
Joint Committee on Health Care Financing
Transcript Highlights:
- If local pharmacies fail, then the health care costs will rise.
- only available at independent pharmacies.
- And as Representative Markey said, they've created a business with health plans, pharmacies, and pharmacy
- What's proprietary is how much they're going to pay a pharmacy.
- I have not seen any... ...placement in paying pharmacies.
Summary:
The Joint Committee on Health Care Financing held a public hearing on a broad set of health care bills focused on cost, market oversight, pharmaceutical access, transparency, hospital closures, and pharmacy access. Chairs John Lawn and Cindy Friedman opened by emphasizing recent health care reforms and the need for further action on the drug supply chain, PBMs, private equity, and affordability. The committee heard testimony on several measures, including a Betsy Lehman Center bill to make technical changes and create a permanent trust account for federal and private funding, and bills on hospital profits and fairness, hospital closures and health planning, pharmacy deserts, and health care market oversight and pharmaceutical access. No votes were taken during the hearing.
On the hospital profits bill, physicians and labor advocates strongly supported capping hospital CEO compensation at 50 times the lowest-paid worker, requiring greater financial transparency, and directing penalties from high-margin public hospitals into a Medicaid reimbursement fund. Testifiers argued that executive pay is excessive while frontline staff and safety-net services are under strain. Committee members raised concerns about unintended consequences, including whether hospitals might shift workers to contract status or lose executive talent, and whether the bill would actually direct money to the safety net. Supporters responded that the measure is one piece of a larger effort and that the bill’s Medicaid reimbursement provisions would help underserved hospitals.
Testimony on market oversight and pharmaceutical access centered on rising health care and drug costs, PBM practices, and the proposal to give the Health Policy Commission authority to set upper payment limits for certain drugs. Consumer advocates, disability advocates, an independent pharmacist, the Attorney General’s office, and others supported stronger oversight, citing premium increases, affordability problems, and the impact of high drug prices on patients and community pharmacies. Pharma and some industry witnesses opposed parts of the bill, warning that upper payment limits could disrupt access, create legal issues, and fail to address the broader supply chain. The committee also heard support for stronger hospital closure notice and public hearing requirements, and for a pharmacy deserts bill aimed at identifying and addressing closures like the one in Roxbury that affected thousands of patients.
CA
California 2025-2026 Regular Session
Assembly Floor Session May 19th, 2025
California House Floor Meeting
Transcript Highlights:
- , not a type of pharmacy, one specific pharmacy.
- The contract pharmacy restrictions also mean clinic's services. ...and meal services.
- The contract pharmacy restrictions also mean clinic systems can't contract with multiple pharmacies that
- This will allow clinics to contract with more pharmacies in the areas that they serve.
- This will allow clinics to contract with more pharmacies in the areas that they serve.
Summary:
The Assembly met after a quorum call, prayer, and Pledge of Allegiance, then moved through a long Daily File with several guest introductions and floor speeches. Members recognized visiting student leaders, championship football teams from Tuolumne County, Alpha Kappa Alpha members at their Capitol day, and later a descendant of Wong Kim Ark. The chamber also adopted a procedural motion allowing certain members to host guests in the rear of the chamber.
Among the major policy items, AB 578 on food delivery platform refund practices passed 47-2, AB 344 on successor beer manufacturer definitions passed 61-0, AB 454 to make California’s migratory bird protections permanent passed 55-12 on the urgency clause, AB 482 updating the Table Grape Commission passed 64-1, AB 1237 to support transit access for 2026 FIFA World Cup ticket holders passed 56-15 on the urgency clause, AB 738 on wildfire rebuild solar exemptions passed 42-2, AB 1460 on 340B pharmacy access for clinics passed 41-5, AB 750 on homeless shelter oversight passed 49-1, AB 1061 on housing in historic districts passed 41-13, AB 1523 on expanding mandatory mediation thresholds passed 65-0, and AB 316 on AI-related civil liability passed 56-0. AB 761 authorizing the Monterey-Salinas Transit District to seek a sales tax ballot measure passed 47-12.
The chamber also adopted several resolutions. AJR 3 urging protection of Social Security, Medicare, and Medicaid passed 53-2 after extensive debate that included criticism of federal cuts and counterarguments focused on state Medi-Cal policy and budget decisions. ACR 65 proclaiming California Tourism Month was adopted by voice vote after coauthors were added, and ACR 62 recognizing California Nonprofits Day was also adopted by voice vote with 65 coauthors. AJR 5 affirming birthright citizenship and opposing efforts to end it passed 58-1 after a lengthy, highly partisan debate centered on the 14th Amendment and the Wong Kim Ark precedent. The session also included passage of AB 571, a CEQA exemption for the Southern California Veterans Cemetery at Gypsum Canyon, which was presented as a long-running bipartisan effort to create a final resting place for Orange County veterans.
AR
Transcript Highlights:
- Subsection 604K, where APRNs are allowed pursuant to Act 961 of 2025 to purchase compounded products.
- Under 604K, I believe he said this is the compound that allows them to purchase compounded products,
- All right, we will go to 13, Department of Health, Arkansas State Board of Pharmacy. provide MAC and
- I'm the director of the Arkansas State Board of Pharmacy. Thank you for being here.
- We have a section for updating compounding rules to match national standards, as well as to allow the
TX
Transcript Highlights:
- It's one single compound isolated of just CBD.
- This compound is an anticonvulsant.
- So, I have seen that at my local independent pharmacy.
- THC was my gateway to pharmacy. legal medicines.
- All these compounds work well in our system.
Bills:
HB5
LA
Transcript Highlights:
- So for instance, the prescription of a compound that mimics, Life and death.
- The Board of Pharmacy has not presented this as an issue.
- It's just the Board of Pharmacy nor the Department of Health has received reports.
- I am a student at the ULM College of Pharmacy, but I am here in my capacity as self.
- Wouldn't get to the pharmacy to get the refills until several days after.
Bills:
SB57, SB405, HB62, HB193, HB203, HB222, HB246, HB420, HB475, HB486, HB574, HB584, HB815, HB949, HB1092, HB1214
Keywords:
SB 57, Act 735, Act 463, nutrition, public health, food additives, artificial colors, banned chemicals, ingredient labeling, food labeling, FDA, food and beverage regulation, consumer disclosure, school nutrition, Louisiana Revised Statutes Title 40, Louisiana Revised Statutes Title 17, food manufacturers, food retailers, compliance, effective date delay
CA
California 2025-2026 Regular Session
Joint Hearing Assembly Health Committee and Senate Health Committee Mar 10th, 2026
Transcript Highlights:
- This is what uncertainty looks like on the ground, and ongoing federal instability compounds existing
- I currently live an hour and 15 minutes away from the nearest pharmacy. From the nearest pharmacy.
- These pressures are compounded by the impacts community safety net providers are facing.
- These pressures are compounded by the impacts community safety net providers are facing, and our health
- Pre-ACA, Tulare County operated two federally qualified health clinics, a pharmacy, and had contracts
Summary:
The joint informational hearing of the Senate and Assembly Health Committees focused on the “cost of uncertainty” in health coverage, access, and affordability amid federal policy changes. Opening remarks from committee leaders and members emphasized that California’s gains under the Affordable Care Act and Health for All policies—high coverage rates, consumer protections, and lower uninsured rates—are now threatened by federal rollbacks, including the expiration of enhanced premium tax credits and H.R. 1. Members repeatedly cited rising premiums, skipped care, medical debt, and the risk of coverage losses, especially for low-income Californians, workers, seniors, and immigrant communities.
The first panel featured federal policy and state implementation experts, including Don Joyce, Jessica Altman of Covered California, and Elizabeth Lansberg of HCAI’s Office of Health Care Affordability. Testimony described the ACA’s coverage expansions and the current federal threats: shorter open enrollment, more verification requirements, loss of enhanced subsidies, and changes affecting immigrants and preventive coverage. Covered California reported that average monthly premiums could nearly double without the subsidies, new enrollment is down sharply, and more consumers are shifting into bronze plans with higher deductibles. HCAI explained its affordability strategy through spending targets, consolidation review, and primary care investment, while members asked about the impact of federal cuts on provider taxes, uncompensated care, and whether California can sustain coverage without new revenue.
The second panel, with UC Berkeley Labor Center’s Miranda Dietz and California Health Care Foundation’s Christoph Stremikis, broadened the discussion to statewide cost drivers and consumer impacts. They highlighted that more than half of Californians under 65 rely on job-based coverage, yet premiums, deductibles, and out-of-pocket costs have risen faster than wages. They also pointed to medical debt, administrative waste, market consolidation, and underinvestment in primary care as major drivers of unaffordability. Members asked about the 25% of health spending that does not improve patient care, the role of fraud versus administrative friction, the effect of cost growth targets on workers, and the need for preventive care and possible revenue solutions. The hearing then moved to a third panel on human impacts, beginning with testimony from a Central Valley promotora describing how families are choosing lower-tier coverage, struggling with diabetes care, and facing higher premiums after subsidy losses.
CA
California 2025-2026 Regular Session
Joint Hearing Senate Health Committee and Assembly Health Committee Mar 10th, 2026
Transcript Highlights:
- This is what uncertainty looks like on the ground, and ongoing federal instability compounds existing
- I currently live an hour and 15 minutes away from the nearest pharmacy.
- These pressures are compounded by the impacts community safety net providers are facing.
- These pressures are compounded by the impacts community safety net providers are facing, and our health
- Pre-ACA, Tulare County operated two federally qualified health clinics, a pharmacy, and had contracts
CA
California 2025-2026 Regular Session
Joint Hearing Assembly Health Committee and Senate Health Committee Mar 10th, 2026
Transcript Highlights:
- This is what uncertainty looks like on the ground, and ongoing federal instability compounds existing
- I currently live an hour and 15 minutes away from the nearest pharmacy. From the nearest pharmacy.
- These pressures are compounded by the impacts community safety net providers are facing.
- These pressures are compounded by the impacts community safety net providers are facing, and our health
- Pre-ACA, Tulare County operated two federally qualified health clinics, a pharmacy, and had contracts
CA
California 2025-2026 Regular Session
Joint Hearing Senate Health Committee and Assembly Health Committee Mar 10th, 2026
Transcript Highlights:
- This is what uncertainty looks like on the ground, and ongoing federal instability compounds existing
- I currently live an hour and 15 minutes away from the nearest pharmacy. From the nearest pharmacy.
- These pressures are compounded by the impacts community safety net providers are facing.
- These pressures are compounded by the impacts community safety net providers are facing, and our health
- Pre-ACA, Tulare County operated two federally qualified health clinics, a pharmacy, and had contracts
Summary:
The joint informational hearing of the Senate and Assembly Health Committees focused on the cost of federal instability for California health coverage, access, and affordability. Opening remarks from members of both houses emphasized that California’s coverage gains under the Affordable Care Act are now threatened by federal policy changes, including the expiration of enhanced premium tax credits, H.R. 1, and new federal regulatory actions. Members repeatedly cited rising premiums, skipped care, medical debt, and the risk that low-income, immigrant, and working Californians could lose coverage or be pushed into less comprehensive plans.
The first panel reviewed the federal landscape and state response. Don Joyce described the ACA’s coverage expansions and warned that H.R. 1, regulatory changes, and broader federal retrenchment could reduce coverage and weaken meaningful benefits. Covered California Executive Director Jessica Altman said the loss of enhanced premium tax credits is driving major affordability problems, with average monthly premiums projected to rise sharply and enrollment already down, especially among middle-income consumers. HCAI’s Elizabeth Lansberg explained the Office of Health Care Affordability’s role in slowing spending growth, monitoring consolidation, and setting spending targets, including lower targets for high-cost hospitals and new primary care investment goals. Members asked about bronze plans, high-cost hospitals, administrative burdens, provider taxes, and whether federal advisory changes could affect required benefits such as immunizations.
The second panel examined population impacts and cost drivers. UC Berkeley Labor Center’s Miranda Dietz said most Californians get coverage through employers, Medi-Cal, or Covered California, and that affordability problems are widespread across all groups. She projected that California could have up to 2 million more uninsured residents by 2030, largely from Medi-Cal losses, and said higher premiums reduce wages and increase medical debt. Christoph Stremakis of the California Health Care Foundation highlighted survey data showing widespread concern about medical bills, skipped care, and medical debt, and argued that a large share of spending is wasted through administrative complexity, inflated prices, and underinvestment in prevention. Committee members pressed the panel on whether California can sustain coverage without new revenue, how cost-growth targets affect workers and families, how medical debt relief programs like Los Angeles County’s could be expanded, and how OCA can address uncompensated care, consolidation, and prior authorization burdens.
NH
New Hampshire 2026 Regular Session
House Environment and Agriculture (02/10/2026)
Environment and Agriculture
Transcript Highlights:
- </c> There are also um board of pharmacy There are also um board of pharmacy requirements<04:14:12.720
- </c><05:42:05.600><c> listed</c> are more than 6 million compounds listed are more than 6 million compounds
- </c> products made with PAS compounds products made with PAS compounds breathing<05:42:28.878><c> air
- PFAS compounds are no longer going to be there, and no progress will be made until compounds are no longer
- </c> making and using these PAS compounds. making and using these PAS compounds.
Summary:
The Environmental Policy Subcommittee took up HB 1621, which would require a baseline environmental impact study before development of certain manufacturing and storage facilities. Members said the concept had merit, but they could not resolve major drafting and implementation issues, including how to define covered facilities, what the study would require, and how enforcement would work at the municipal or county level. Several members expressed concern about unintended consequences and said the proposal was not ready; the subcommittee voted unanimously to recommend inexpedient to legislate (ITL), and the full committee later adopted that recommendation on a 16-0 roll call vote, placing the bill on consent.
The committee then discussed HB 1053, involving electronically submitted pesticide use reports. Representative Comtois presented an amendment creating a department database and protecting confidential information, but said she still needed to check whether it was germane and to review administrative issues with the Department of Agriculture. After hearing from David Russo of the Division of Pesticide Control, the committee agreed to continue work on the amendment and took no action that day.
The committee also reviewed HB 1186 on egg labeling and producer exemptions. Representative Comtois offered an amendment exempting small producers from most requirements except labeling, but Commissioner Sean Jasper asked for more time to review the impact and suggested the state might not need the existing egg law at all if federal USDA rules already cover the field. Members agreed to hold action until the following week. Finally, the committee began discussion of HB 1780 on penalties for violations involving seeds, plants, and nursery stock, focusing on labeling rules and germination-date requirements; testimony from industry and department representatives indicated they were working toward a compromise that would allow multiple relabelings, add production dates, and set a 36-month sale limit, but no final action was taken in the portion provided.
WA
Washington 2025-2026 Regular Session
Senate Health & Long-Term Care Jan 16th, 2026
Transcript Highlights:
- Whole Health Pharmacy is an independent community pharmacy that serves as a 340B contract pharmacy for
- We're now in a pharmacy desert with all of these pharmacies.
- pharmacies shut down.
- What we got from the contract pharmacy and retail pharmacy benefits was only $318 million.
- What we got from the contract pharmacy and retail pharmacy benefits was only $318 million.
Summary:
The Senate Health and Long-Term Care Committee held a hearing on several bills. SB 5904 would prohibit non-human entities from using nursing titles; the sponsor and nursing groups said it is meant to increase transparency around AI and ensure patients know when they are interacting with a real nurse. SB 5915 would change Health Technology Assessment Program review criteria and timelines, with supporters arguing it would better account for Medicare coverage and national guidelines, especially for rare and life-threatening conditions. SB 6025 would update the definition of fetal death to allow gestational age to be determined by the best clinically accurate method rather than last menstrual period, and medical professionals and the sponsor said this would reduce emotional, financial, and legal burdens on grieving families. SB 5933 would require near real-time sharing of overdose data into ODMAP; public health, local government, and recovery advocates said it would improve overdose response, while one witness asked that poison center data be included and clarified separately. SB 5990 would allow APRNs and physician assistants to serve as local health officers in counties under 100,000 population; rural county officials supported the added flexibility, while public health groups and naturopathic physicians raised concerns about qualifications and asked that naturopathic doctors be included as well. SB 5981 would restrict drug manufacturers from limiting 340B drug access through contract pharmacies or requiring data as a condition of discounts; safety-net hospitals, community health centers, pharmacies, and patients said it protects access and reinvestment in care, while manufacturers, employer groups, and industry representatives argued it increases costs, lacks transparency, and may not ensure savings reach patients.
No votes or final committee actions were taken in the transcript; each bill was heard and testimony was closed. Sign-in counts were reported for several bills, including strong pro support for SB 5904, SB 5915, SB 5933, and SB 5981, and mixed or substantial opposition on SB 6025 and SB 5990.
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Financial Services Jun 21st, 2026 at 12:30 pm
Joint Committee on Financial Services
Transcript Highlights:
- And here's the key: they have to be filled at pharmacies for insurance to cover it, but not medications
- gap that I just mentioned, that insurance will cover it if it's prescribed and then dispensed at a pharmacy
- All of this compounds, and it is very disruptive to our patients' quality of life, leading to an increase
- ... ...compounds and is very disruptive to our patients' quality of life, leading to an increased risk
- So it took months of trial and error and especially compounded medication to protect my skin.
Summary:
The Joint Committee on Financial Services held a public hearing on a wide range of bills, with testimony first focused on H. 1315/S. 824, which would require insurance coverage for pain management options during IUD insertion. Representative Sabadosa, Planned Parenthood clinicians, and policy advocates said sedation can reduce fear and trauma, improve access to effective contraception, and should be reimbursed so providers can continue offering it. A Tufts OB-GYN resident also testified that pain control should be standard care for intrauterine procedures. No votes were taken during the hearing.
The committee then heard extensive testimony on firefighter health bills, especially H. 1230/S. 690 requiring insurance coverage for cancer screenings for firefighters. Professional Fire Fighters of Massachusetts leaders, a Dana-Farber oncologist, and firefighters themselves described occupational exposure to carcinogens and personal stories of late-stage cancer detection, arguing that early screening can save lives and reduce long-term costs. Representative Crichton and Representative Howitt also spoke in support, and Representative Ayers testified for H. 4012, which would require neurological disorder screenings for firefighters. Committee members expressed support and sympathy, but no action was taken.
The hearing also covered H. 3946/S. 756 on hearing aid coverage, with testimony from students, adults with hearing loss, disability advocates, and HLAA representatives describing the educational, social, and financial barriers caused by lack of coverage and urging broader insurance mandates. Later, Representative Donahue and Representative Vargas testified for H. 1337 to expand insurance coverage for opioid antagonists and related medications, including naloxone dispensed at discharge. The committee additionally heard testimony on H. 1134 to improve chronic pain care coordination and non-opioid access, and H. 4162 to improve ostomy supply coverage and access to certified ostomy care, with patients and clinicians describing denials, quantity limits, and non-medical switching. The transcript ends while testimony on H. 1315/S. 824 is still ongoing; no votes or formal committee actions are recorded in the excerpt.
NH
New Hampshire 2026 Regular Session
House Environment and Agriculture (02/10/2026)
Environment and Agriculture
Transcript Highlights:
- >> 318E allows law enforcement agencies, registered pharmacies, long-term care facilities, and others
- There are also Board of Pharmacy requirements, and the Department of Justice has rules that govern how
- </c> There are also um board of pharmacy There are also um board of pharmacy requirements<04:14:12.720
- In terms of what individual pharmacies do with those drugs, the witness said, "I don't have that exact
- </c><05:42:05.600><c> listed</c> are more than 6 million compounds listed are more than 6 million compounds
TX
Transcript Highlights:
- Which seeks to establish parity between traditional and compounding pharmacies pharmacies by implementing
- My name is Randan Ching, and I'm an independent. pharmacy or pharmacist that runs a Tarrytown Pharmacy
- , a small business pharmacy here in Austin, Texas.
- , you can walk into any. any chain pharmacy, independent pharmacy, and ask to speak with a pharmacist
- pharmacy tech. Yeah, so pharmacy technicians, they do a lot on the pharmacy.
Bills:
HB 3772, HB 1656, HB 4504, HB 1896, HB 4420, HB 4421, HB 4076, HB 3708, HB 2806, HB 3540, HB 1586, HB 5459, HB 4553, HB 4535, HB 3811, HB 3749, HB 4255, HB 4051, HB 5098, HB 3554, HB 4539, HB 5274
Keywords:
e-cigarettes, health and safety, regulations, directory, penalties, regulation, certification, compliance, manufacturers, FDA, nicotine, mental health, emergency detention, paramedic authority, mental illness, healthcare facility, public health, covenants not to compete, health care practitioners, physicians
NV
Nevada 2025 Regular Session
Senate Floor Session May 29th, 2025 at 11:00 am
Nevada Senate Floor Meeting
Transcript Highlights:
- defines and clarifies net price paid and rebate, and eliminates sections related to limitations on pharmacy
- Senate Bill 316, as amended, revises various provisions relating to pharmacy benefit managers by expanding
- cetera, urges Congress to take certain actions relating to the therapeutic use of certain psychedelic compounds
- cetera, urges Congress to take certain actions relating to the therapeutic use of certain psychedelic compounds
- Supervised adult use of psychedelic compounds. Any further remarks on the motion?